Helix BioPharma Corp. (HBP.TO) TSX
Currency In CAD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 59.64M |
| Enterprise Value | 59.91M |
| P/E Ratio | -34.09 |
| PEG Ratio | -0.12 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 7.8 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -36.34 |
Fiscal Year
| Fiscal Year | July 31, 2025 |
| Most Recent Quarter | April 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.16 |
| Return On Equity | -0.22 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -10,000 |
| EBITDA | -5.21M |
| Net Income | -5.21M |
| Diluted EPS | -0.09 |
Balance Sheet
| Total Cash | 2.84M |
| Total Cash/Share | 0.04 |
| Total Debt | 359,000 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 0.45 |
| Book Value Per Share | 0.19 |
Price History
| 52-Week Change | 61.29 |
| 52-Week High | 5.4 |
| 52-Week Low | 0.84 |
| Moving Average 50 Days | 1.73 |
| Moving Average 200 Days | 2.01 |
Statistics
| Average Volume | 2,133 |
| Shares Outstanding | 76.38M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | August 16, 2024 |
AD
